• Cognitive Behavioral Therapy Reduces COPD-related Anxiety and Hospital Visits, Study Shows
  • Exosomes Released by Immune Cells Can Cause COPD, Study Finds
  • Verona Pharma’s Candidate RPL554 for COPD Will Be Named Ensifentrine
  • ProAir Digihaler Approved for COPD and Asthma Patients to Digitally Track Their Albuterol Use
  • European Commission OKs Bevespi Aerosphere for Adults With COPD
  • Endobronchial Valve System Now Approved in US for Treatment of Severe Emphysema
  • Verona Pharma’s Phase 2 Trial Evaluating RPL554 for COPD Set to Begin
  • Obesity Strongly Linked to COPD in Individuals Who Never Smoked, Study Reports
  • Few COPD Patients Enroll in Pulmonary Rehabilitation, Despite Benefits, Study Shows
  • Mucus Protects Lungs by Forming Layers, Preventing Worsening of Lung Diseases, Studies Reveal
  • Royal Philips Launching Motivational and Awareness Campaign to Mark World COPD Day
  • FDA Approves Yupelri as New Treatment for Adults with COPD